PubRank

Hannes Steiner

Author PubWeight™ 50.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol 2004 3.15
2 Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002 2.37
3 Early diagnosis and straight forward surgery of an asymptomatic primary angiosarcoma of the kidney led to long-term survival. Int J Urol 2006 1.92
4 Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 2005 1.73
5 Large-scale study of clinical impact of PSA velocity: long-term PSA kinetics as method of differentiating men with from those without prostate cancer. Urology 2007 1.69
6 Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int 2008 1.68
7 Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk. Prostate 2005 1.68
8 Safer transurethral resection of the prostate: coagulating intermittent cutting reduces hemostatic complications. J Urol 2004 1.54
9 Endoscopic application of dextranomer/hyaluronic acid copolymer in the treatment of vesico-ureteric reflux after renal transplantation. BJU Int 2010 1.44
10 Model-based optimal design of polymer-coated chemical sensors. Anal Chem 2003 1.43
11 Late penile metastasis from primary bladder carcinoma. Urology 2003 1.32
12 Expression and function of androgen receptor coactivators in prostate cancer. J Steroid Biochem Mol Biol 2004 1.31
13 Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor. Endocr Relat Cancer 2008 1.30
14 The anti-interleukin-6 antibody siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study. Prostate 2011 1.13
15 Androgen receptors in prostate cancer. J Urol 2003 1.07
16 Occurrence of polyorchidism in a young man. Urology 2002 1.05
17 Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia. Prostate 2003 0.99
18 Orthotopic bladder replacement in women: focus on functional results of a retrospective, single-centre study. Scand J Urol 2013 0.95
19 Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Prostate 2005 0.92
20 Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report. Urology 2007 0.92
21 Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study. Urology 2003 0.91
22 Mcl-1 is regulated by IL-6 and mediates the survival activity of the cytokine in a model of late stage prostate carcinoma. Adv Exp Med Biol 2008 0.91
23 The androgen receptor pathway is by-passed in prostate cancer cells generated after prolonged treatment with bicalutamide. Prostate 2006 0.90
24 Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. Urology 2003 0.90
25 Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer. Am J Pathol 2006 0.90
26 Vascular damage as a risk factor for benign prostatic hyperplasia and erectile dysfunction. BJU Int 2005 0.89
27 Molecular cytogenetic analysis of human spermatocytic seminomas. J Pathol 2004 0.88
28 Long-term results of laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testicular cancer. J Endourol 2007 0.87
29 Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center. J Urol 2006 0.86
30 Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens. Prostate 2003 0.85
31 Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. Eur Urol 2002 0.85
32 Organ-sparing surgery is the treatment of choice in benign testicular tumors. World J Urol 2013 0.83
33 A comparison of one-stage procedures for post-traumatic urethral stricture repair. BJU Int 2005 0.83
34 Another novel application of Hem-o-Lok clips for transient vascular occlusion in robot-assisted laparoscopic partial nephrectomy: an alternative to laparoscopic bulldog and Satinsky clamps. J Endourol 2008 0.83
35 Organ-sparing surgery does not lead to greater antisperm antibody levels than orchidectomy. BJU Int 2007 0.82
36 Increased incidence of Leydig cell tumours of the testis in the era of improved imaging techniques. BJU Int 2011 0.82
37 Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens. Prostate 2002 0.81
38 Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res 2012 0.80
39 Splenosis mimicking local recurrence after laparoscopic radical nephrectomy. Urology 2003 0.80
40 Influence of achieved paternity on quality of life in testicular cancer survivors. BJU Int 2012 0.79
41 In young adults with a low body mass index ultrasonography is sufficient as a diagnostic tool for ureteric stones. BJU Int 2011 0.79
42 Management of adult Leydig-cell testicular tumors: assessing the role of laparoscopic retroperitoneal lymph node dissection. J Endourol 2003 0.78
43 Management of incidental impalpable intratesticular masses of < or = 5 mm in diameter. BJU Int 2006 0.78
44 Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population. Urology 2006 0.77
45 Routine scrotal ultrasonography during the follow-up of patients with testicular cancer leads to earlier detection of asynchronous tumours and a high rate of organ preservation. BJU Int 2009 0.77
46 Metastasizing renal cell carcinoma developing in a congenital ectopic and dysplastic kidney. Urol Int 2008 0.76
47 The sword of Damocles and the treatment of stage I seminoma. J Clin Oncol 2006 0.75
48 Chemometric correction of drift effects in optical spectra. Appl Spectrosc 2004 0.75
49 Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C. BJU Int 2008 0.75
50 Transurethral microwave thermotherapy (TUMT) with the Targis System: a single-centre study on 78 patients with acute urinary retention and poor general health. Eur Urol 2003 0.75
51 Intravesical free-floating prostate. J Urol 2002 0.75
52 Long target droplet polymerase chain reaction with a microfluidic device for high-throughput detection of pathogenic bacteria at clinical sensitivity. Biomed Microdevices 2011 0.75
53 Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76. Transfusion 2013 0.75
54 De novo renal cell carcinoma in a kidney allograft with focus on contrast-enhanced ultrasound. Urol Int 2014 0.75
55 Hydronephrosis Predicts Successful Catheter Removal after Painful Urinary Retention - Preliminary Results of a Prospective Single Center Study. Urol Int 2015 0.75
56 Unrecognized paraganglioma of the urinary bladder as a cause for basilar-type migraine. Urol Int 2013 0.75
57 Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series. Chemotherapy 2013 0.75
58 The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-up. Anticancer Res 2013 0.75